Pancreas-brain axis: exploring the pathogenic mechanisms of pancreatic encephalopathy
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.116332 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Ni-Nan Dai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China; Severe Acute Pancreatitis Diagnosis and Treatmen…. Hauptthemen laut MEDLINE: Brain Diseases, Brain, Pancreas, Pancreatitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 201 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Pancreatic encephalopathy (PE) is a severe yet under-recognized neurological complication of acute pancreatitis, characterized by disturbances in consciousness, cognitive impairment, and high mortality. Recent epidemiological evidence indicates that PE occurs more frequently than previously appreciated, particularly in patients with severe disease. The pathogenesis of PE is multifactorial and involves pancreatic enzyme-mediated toxicity, systemic inflammation, metabolic dysregulation, and blood-brain barrier disruption. Emerging studies support the concept of a bidirectional pancreas-brain axis, through which pancreatic injury signals are transmitted to the central nervous system via integrated neural, endocrine, immune, and microbiota-related pathways. This review synthesizes the current evidence on the molecular, cellular, and network-level mechanisms underlying PE, with a focus on neuro-glial-immune interactions, excitotoxicity, mitochondrial dysfunction, and neuroinflammation. We summarize advances in diagnostic biomarkers and discuss the translational potential of emerging therapeutic strategies, including neuromodulation, mitochondrial protection, and short-chain fatty acid supplementation. By providing an integrated framework of the pancreas-brain axis, this review aims to clarify the pathophysiology of PE and highlight future directions for diagnostic and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China; Severe Acute Pancreatitis Diagnosis and Treatment Center of Guizhou Province, Zunyi, China.
- Key Laboratory of Anesthesia and Organ protection of Guizhou Province, Zunyi Medical University, Zunyi, China.
- Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China; Severe Acute Pancreatitis Diagnosis and Treatment Center of Guizhou Province, Zunyi, China. Electronic address: zyyxyf…
- Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China; Key Laboratory of Anesthesia and Organ protection of Guizhou Province, Zunyi Medical University, Zunyi, China. Electro…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Dai, N. N., Geng, Z. G., Wang, J., Bu, X. L., Gong, M. Y., Qin, C., Zhang, Y., Fu, X. Y., & Fu, B. (2026). Pancreas-brain axis: exploring the pathogenic mechanisms of pancreatic encephalopathy. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116332
Vancouver
Dai NN, Geng ZG, Wang J, Bu XL, Gong MY, Qin C, et al. Pancreas-brain axis: exploring the pathogenic mechanisms of pancreatic encephalopathy. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.116332
BibTeX
@article{Dai2026,
author = {Dai, Ni-Nan and Geng, Zheng-Guang and Wang, Jing and Bu, Xiao-Li and Gong, Ming-Yang and Qin, Chang and Zhang, Yu and Fu, Xiao-Yun and Fu, Bao},
title = {Pancreas-brain axis: exploring the pathogenic mechanisms of pancreatic encephalopathy},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.116332}
}
EUVIMED